Home › Non-Muscle Invasive Bladder Cancer › Texas
Non-Muscle Invasive Bladder Cancer clinical trials in Texas
15 studies for Non-Muscle Invasive Bladder Cancer are looking for participants at sites in Texas.
Cities in Texas
A Clinical Study of Intismeran Autogene (V940) and BCG in People With Bladder Cancer (V940-011/INTerpath-011)
- Texas Oncology-Austin Central ( Site 0107), Austin
- Urology Austin, PLLC ( Site 0109), Austin
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Oct 1, 2026 · NCT06833073Efficacy and Safety of TYRA-300 in Participants With FGFR3 Altered Low Grade, Intermediate Risk Non-Muscle Invasive Bladder Cancer
- Urology Austin, Austin
- Urology Clinics of North Texas, Dallas
- Baylor College of Medicine, Houston
- and 1 more
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 29, 2026 · NCT06995677A Study to Evaluate TAR-210 Versus Intravesical Chemotherapy Treatment in Participants With High Risk Non-Muscle-Invasive Bladder Cancer
- Texas Oncology-Austin, Austin
- Urology Austin, Austin
- Urology San Antonio PA dba USA Clinical Trials, San Antonio
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 28, 2026 · NCT06919965A Study to Learn About the Study Medicine PF-08052667 in People With Bladder Cancer
- Cancer Center Outpatient Building, Dallas
- The University of Texas Southwestern Medical Center, Dallas
- UT Southwestern Medical Center - West Campus Building, Dallas
- and 5 more
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 28, 2026 · NCT07206225A Study to Assess Real-World Use and Outcomes of TAR-200 for Participants With Non-Muscle Invasive Bladder Cancer (NMIBC) in the United States
- UPNT Research Institute, Arlington
- UT Southwestern Medical Center, Dallas
RecruitingObservational study
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT07309445Replacing Invasive Cystoscopy With Urine Testing for Non-muscle Invasive Bladder Cancer Surveillance
- UT Southwestern Medical Center, Dallas
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 16, 2026 · NCT05796375Safety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder Cancer
- Urology Partners of North Texas, Arlington
- Urology Austin, LLC, Austin
- Houston Metro Urology, Houston
- and 2 more
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Aug 24, 2026 · NCT05951179Artificial Intelligence Prediction Tool in Non-muscle Invasive Bladder Cancer (NMIBC)
- University of Texas Southwestern Medical Center, Dallas
- University of Texas Health Science Center at San Antonio, San Antonio
RecruitingObservational study
Ages 18 to 99 · All sexes · Updated Aug 24, 2026 · NCT05825950Efficacy and Safety of Intravesical TARA-002 Compared With Investigator's Choice of Intravesical Chemotherapy in Participants With BCG-naïve High-grade Non-muscle Invasive Bladder Cancer
- Urology Partners of North Texas, Arlington
- Houston Metro Urology, Houston
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Aug 21, 2026 · NCT07480356FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3
- University of Texas Southwestern, Dallas
- Texas Oncology, P.A, Dallas
- MD Anderson Cancer Center, Houston
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Aug 20, 2026 · NCT05614739Sample Collection for Ongoing Research and Product Evaluation Study - Non-muscle Invasive Bladder Cancer (SCORE-NMIBC)
- Natera, Inc., Austin
RecruitingObservational study
Ages 18 and older · All sexes · Updated Aug 13, 2026 · NCT07763197LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve
- Urology Austin, Austin
- UT Southwestern Medical Center, Dallas
- Houston Metro Urology, Houston
- and 2 more
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Aug 7, 2026 · NCT04752722Specimen Collection for Validation of UroAmp: A Next Generation Sequencing Platform for Detection and Surveillance of Bladder Cancer
- UT Southwestern Medical Center, Dallas
RecruitingObservational study
Ages 18 and older · All sexes · Updated Jun 29, 2026 · NCT07673016A Study of STM-416 Administered to Patients Undergoing TURBT for Recurrent Bladder Cancer
- University of Texas Southwestern Medical Center, Dallas
- Urology Partners of North Texas, Fort Worth
- Baylor College of Medicine, Houston
- and 2 more
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated May 27, 2026 · NCT05710848Blue Light Cystoscopy With Cysview® Registry
- UT Southwestern, Dallas
- Michael E. DeBakey VA Medical Center, Houston
RecruitingObservational study
Ages 18 and older · All sexes · Updated Dec 18, 2025 · NCT02660645From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.